MENLO PARK, Calif.--(BUSINESS WIRE)--RapidAI, the worldwide leader in advanced imaging for stroke, today announced the launch of RapidAI Insights. A unique new analytics platform, RapidAI Insights presents Rapid® scan, treatment, and outcomes data to help hospitals and systems make more-informed business decisions, reduce costs across sites, while simultaneously improving patient outcomes, and saving more lives.
RapidAI Insights offers a portfolio of analytic reports and is a valuable solution for multi-site systems and referral networks looking to standardize stroke care processes and optimize operational efficiencies.
Optimizes operational efficiency and effectiveness: RapidAI Insights provides multi-site systems with the intelligence to help monitor the adoption of Rapid products and evaluate return-on-investment (ROI) across sites.
Improves processes for emergent stroke care: By combining operational, clinical, and imaging data, RapidAI Insights offers customized reports to deliver deep insights on patient care decisions, treatment effectiveness, and platform usage quality in helping to quickly diagnose and treat stroke patients leading to faster intervention and improved patient outcomes.
Increases usage and improves scan protocols: RapidAI Insights enables hospitals to monitor the usage of the Rapid platform by site and proactively ensure proper and consistent use of Rapid products across sites.
Enables easier data monitoring and security: RapidAI Insights gives hospital IT and security team members peace of mind on who has access to and is using Rapid products.
"At RapidAI we focus on helping hospitals save lives, save time and save money," said Don Listwin, CEO of RapidAI. "Developed with intelligence from over 1,500 sites already using Rapid, RapidAI Insights utilizes the massive amount of critical site and system-wide stroke imaging data to deliver hospitals a best-in-class analytic tool that informs their patient care, as well as the economics of their stroke care business. RapidAI Insights addresses the needs of clinicians, IT departments, and hospital administrators."
RapidAI Insights Reports Include
- Rapid Stats and Usage Insights: A suite of reports that offer data on Rapid utilization, scan details and demographics, and scan quality.
- Executive Insights: An executive-level report that offers an information-rich summary of site-specific information across systems for those looking to optimize operational efficiencies and reduce costs.
- Security and Monitoring Insights: Designed to help hospitals support best practices in security, monitoring and compliance auditing; the Security and Monitoring Insights provide IT teams with information on Rapid Mobile App access and usage.
- Patient Journey and Clinical Outcomes Insights: A customized report that delivers hospitals a detailed view into the patient journey and clinical outcomes to help drive stroke protocol improvements.
"As an Interventional Neuroradiologist for a large system, I understand the tremendous value in seeing stroke imaging metrics across patients and our dozens of hospitals in multiple states," said Daniel P. Gibson, MD, and Director, Neurointerventional Surgery. "Analytics coming out of RapidAI Insights help us better understand the opportunities and challenges, which greatly benefit our patients, from the timeliness of care to informing how we handle transfer decisions. In parallel, it also helps our administrators better understand our work from a business perspective."
To learn more about RapidAI Insights, as well as the Rapid platform, visit www.RapidAI.com
RapidAI is the worldwide leader in advanced imaging for stroke. Installed in over 1,500 hospitals in more than 50 countries, the Rapid imaging platform, powered by artificial intelligence, includes Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS. RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke patients using clinically proven, data-driven technology. With our validated, trusted platform, developed by stroke experts, clinicians worldwide are improving patient care and outcomes every day. The Rapid platform has been shown to aid in patient selection in both early and late-window clinical stroke trials. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, the results of these trials led to new American Heart Association and American Stroke Association treatment guidelines and have dramatically altered the management of acute stroke around the world. For more information, visit RapidAI.com.